Indian Journal of Pathology and Microbiology (ISSN-0377-4929)
The Indian Journal of Pathology and Microbiology is the
official Quarterly publication of the Indian Association of
Pathologists and Microbiologists. It had completed 50 glorious years
in the year 2007. Late Dr Vanmali Saran Maglik of King George
Medical College, Lucknow is the founder editor who started the
journal in the year 1958. Initially the journal was called Indian
Journal of Pathology and Bacteriology and the present name is in
existence from the year 1965. The journal grew over the years under
the able guidance of stalwarts like Late Dr HI Jhala, Late Dr V
Ramalingaswamy, Dr HD Tandon, Late Dr BK Aikat and Late Dr S
Nagalotimath. The present form is due to the untiring efforts of Dr
KS Ratnakar, Dr VH Talib, Dr SK Shahi and Dr Harsh Mohan. The journal is widely read and is in almost all the
libraries of the country and in many institutions outside the
country. From the year 2008, the article submission, review,
correspondence and publication process has been made online (www.journalonweb.com/ijpm).
Now the journal has its own website (www.ijpmonline.org). With these
changes the visibility and popularity of the journal has
tremendously increased. Dr S Satyanarayana is the present editor of
Abstracting and Indexing Information
The journal is registered with the following abstracting partners:
Baidu Scholar, CNKI (China National Knowledge Infrastructure), EBSCO Publishing's Electronic Databases, Ex Libris – Primo Central, Google Scholar, Hinari, Infotrieve, National Science Library, ProQuest, TDNet, Wanfang Data
The journal is indexed with, or included in, the following:
DOAJ, EMBASE/ Excerpta Medica, Indian Science Abstracts, IndMed, MEDLINE/Index Medicus, Scimago Journal Ranking, SCOPUS, Science Citation Index Expanded, Web of Science
as reported in the 2022 Journal Citation Reports®
(Clarivate Analytics, 2023): 1
Wolters Kluwer and Journal/Association are committed to meeting and upholding standards of ethical behavior at all stages of the publication process. We follow closely the industry associations, such as the Committee on Publication Ethics (COPE), International Committee of Medical Journal Editors (ICMJE) and World Association of Medical Editors (WAME), that set standards and provide guidelines for best practices in order to meet these requirements. For a summary of our specific policies regarding duplicate publication, conflicts of interest, patient consent, etc., please visit www.Medknow.com/EthicalGuidelines.asp
Open Access Publication and Creative Commons Licensing
This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
Wolters Kluwer Medknow provides for long-term digital preservation through two primary partnerships, Portico and CLOCKSS.
Portico is a leading digital preservation service worldwide. The content is preserved as an archival version and is not publically accessible via Portico, but is provided when required under specific conditions, such as discontinuation of the collection or catastrophic failure of the website.
CLOCKSS will enable any library to maintain their own archive of content from Wolters Kluwer Medknow and other publishers, with minimal technical effort and using cheaply available hardware.
Ahead of Print policy
Articles published online under the Ahead of Print model are considered published and can be cited and quoted using the DOI as the reference source. Wolters Kluwer Medknow has a policy that changes will not be made after publication of an article without following accepted procedures for making corrections to the scientific record.
While advertisements are crucial to this journal to be able to keep all content free for everyone, ethical considerations are in place to ensure the integrity of the journal and its content:
- "Pop-up" and "banner" ads appear on a random, rotating basis. The advertiser has no control or input over the pages where their ads appear.
- The Editorial Board has full and final approval over the content of all advertisements.
- Advertisers will never be shown any manuscripts or other content prior to publication.
From The Editor’s Desk
Wishing you a very Happy New Year 2023. At the outset, I would thank everyone who entrusted their faith in electing me as the new Editor-In-Chief of our journal.
The impact factor of the journal has been steadily maintained and we hope to bring it to a higher level with more quality-based publications, especially original articles, and reviews.
I sincerely believe to enhance the value system by promoting excellence in research through the journal. Good research is scientifically and ethically sound. Every investigator and the author must be conscious and conscientious of the scientific and ethical aspects while preparing a manuscript. Careful attention to the journal guidelines during the formulation of a manuscript can reduce the overall turnaround time for the review process.
The value of time-tested morphology and immunohistochemistry in a clinical context cannot be overemphasized. However, it is prime time to include molecular pathology, to enhance objectivity in the diagnosis and be able to provide more information from the prognostic and predictive aspect which is relevant for patient care. Manuscripts with quality data, offering novel insights have higher chances of acceptance.
I thank the associate editors, all the authors, reviewers, and members of the editorial board who have so far contributed towards maintaining the quality of the journal and look further to their continuous support.
MD, DNB, MIAC, FICP, MCAP(Affl.), FRC-Path, Professor/Pathologist,
Department of Surgical Pathology, Tata Memorial Hospital,
Mumbai, Maharashtra, India.
E-mail: [email protected]